These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 18932068)

  • 1. Iran's Coping Experiences with COVID-19: Strategies and Recommendations.
    Peyravi M; Soltani A; Ahmadi M; Ahmadi Marzaleh M
    Disaster Med Public Health Prep; 2022 Jun; 16(3):845-846. PubMed ID: 33203494
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygosity for the severe β(+)-thalassemia mutation [IVS-I-5 (G>C)] causes the phenotype of thalassemia trait: an extremely rare presentation.
    Bohara V; Raut L; Badarkhe G; Roy SS; Chaudhuri U
    Hemoglobin; 2013; 37(1):101-5. PubMed ID: 23234478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shine & Lal index as a predictor for early detection of β-thalassemia carriers in a limited resource area in Bandung, Indonesia.
    Maskoen AM; Reniarti L; Sahiratmadja E; Sisca J; Effendi SH
    BMC Med Genet; 2019 Aug; 20(1):136. PubMed ID: 31399060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational spectrum of delta-globin gene in the Portuguese population.
    Morgado A; Picanço I; Gomes S; Miranda A; Coucelo M; Seuanes F; Seixas MT; Romão L; Faustino P
    Eur J Haematol; 2007 Nov; 79(5):422-8. PubMed ID: 17916081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
    Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusually frequent beta-thalassemia mutation in an Iranian Province.
    Eshghi P; Zadeh-Vakili A; Rashidi A; Miri-Moghaddam E
    Hemoglobin; 2008; 32(4):387-92. PubMed ID: 18654889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and importance of accurate Hb A2 measurements for defining a strategy for β-thalassemia screening: experience in the Balearic Islands, Spain.
    López-Escribano H; Parera MM; Guix P; Castro JA; Ramon M; Picornell A
    Hemoglobin; 2013; 37(6):593-8. PubMed ID: 23952214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masking of a β-thalassemia determinant by a novel δ-globin gene defect [Hb A2-Saurashtra or δ100(G2)Pro→Ser; HBD: c.301C>T] in Cis.
    Colaco S; Trivedi A; Colah RB; Ghosh K; Nadkarni AH
    Hemoglobin; 2014; 38(1):24-7. PubMed ID: 24200152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological phenotype of the IVS-I-5 (G > C) beta-thalassemia mutation and assessment of Iran's national screening criteria.
    Eshghi P; Rashidi A; Zadeh-Vakili A; Miri-Moghadam E
    Hemoglobin; 2008; 32(5):440-5. PubMed ID: 18932068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse hematological phenotypes of β-thalassemia carriers.
    Luo HY; Chui DH
    Ann N Y Acad Sci; 2016 Mar; 1368(1):49-55. PubMed ID: 27123947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUPT5H mutations associated with elevation of Hb A
    Lin Z; Liang X; Wei X; Liang G; Zhu D; Xie H; Yan T; Shang X
    Gene; 2024 May; 908():148294. PubMed ID: 38373659
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.